| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,223 |
11,128 |
$1.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,753 |
5,120 |
$1.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,498 |
1,267 |
$296K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,148 |
1,044 |
$90K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,492 |
2,344 |
$66K |
| G0378 |
Hospital observation service, per hour |
271 |
209 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,175 |
10,056 |
$46K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,286 |
2,996 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,113 |
3,587 |
$26K |
| 80053 |
Comprehensive metabolic panel |
8,383 |
6,909 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
844 |
755 |
$16K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
185 |
172 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
973 |
825 |
$14K |
| 84484 |
|
1,137 |
961 |
$11K |
| 83690 |
|
2,623 |
2,267 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
756 |
400 |
$11K |
| 87430 |
|
1,669 |
1,569 |
$10K |
| 82150 |
|
2,569 |
2,221 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
235 |
225 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,499 |
2,096 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
2,602 |
2,275 |
$7K |
| 81001 |
|
8,360 |
7,268 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
6,464 |
4,980 |
$5K |
| 81025 |
|
1,842 |
1,689 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
470 |
404 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
25 |
25 |
$3K |
| 85730 |
|
936 |
814 |
$3K |
| 87807 |
|
391 |
385 |
$3K |
| 43249 |
|
15 |
13 |
$2K |
| 83880 |
|
304 |
253 |
$2K |
| 83605 |
|
364 |
306 |
$2K |
| 85610 |
|
1,257 |
1,068 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
46 |
42 |
$2K |
| 87081 |
|
487 |
464 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
48 |
39 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
79 |
67 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
12 |
$1K |
| 87040 |
|
261 |
216 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
364 |
320 |
$1K |
| 80305 |
|
150 |
132 |
$912.19 |
| 85379 |
|
127 |
111 |
$715.73 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
203 |
135 |
$681.45 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
161 |
138 |
$659.59 |
| 83735 |
|
221 |
166 |
$426.72 |
| 80306 |
|
84 |
72 |
$342.86 |
| 74018 |
|
56 |
49 |
$248.98 |
| 71046 |
Radiologic examination, chest; 2 views |
40 |
36 |
$164.14 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
27 |
26 |
$141.12 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$100.28 |
| J3490 |
Unclassified drugs |
16 |
13 |
$89.97 |
| 86850 |
|
211 |
176 |
$61.39 |
| 86900 |
|
211 |
176 |
$31.00 |
| 82962 |
|
141 |
84 |
$29.87 |
| 86901 |
|
211 |
176 |
$29.51 |
| 80076 |
|
17 |
14 |
$27.22 |
| A9270 |
Non-covered item or service |
330 |
253 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
203 |
165 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |